Cellular Membranes and Lipid Mediator Pathways

Cellular Membranes and Lipid Mediator Pathways represent the integrated biochemical system responsible for the liberation of polyunsaturated fatty acids from membrane phospholipids and their subsequent conversion into bioactive eicosanoids (Dennis & Norris, 2015). This process is primarily initiated by Phospholipase A2 (PLA2) enzymes, which respond to inflammatory or physiological stimuli by cleaving arachidonic acid from the cell membrane bilayer (Funk, 2001). The resulting free arachidonic acid serves as a substrate for three major enzymatic branches: the cyclooxygenase (COX) pathway, leading to prostaglandins and thromboxanes; the lipoxygenase (LOX) pathway, leading to leukotrienes; and the cytochrome P450 pathway (StatPearls, 2023). These lipid mediators act as potent autacoids, regulating diverse functions including vascular tone, platelet aggregation, bronchial constriction, and the recruitment of immune cells (Haeggström & Funk, 2011). Dysregulation of these pathways is a central driver in chronic inflammatory diseases, asthma, and cardiovascular pathology, making them a primary focus for pharmacological intervention (Wang & Dubois, 2010). Drugs such as NSAIDs and leukotriene modifiers exert their therapeutic effects by selectively inhibiting specific enzymes or receptors within this broad network to alleviate pain and resolve inflammation (StatPearls, 2023).

Other names

Arachidonic acid cascadeEicosanoid signaling pathwayLipid signaling networkPolyunsaturated fatty acid metabolism

Pharmacological agents modulate this system by inhibiting key biosynthetic enzymes such as cyclooxygenases (COX-1/2) and lipoxygenases (5-LOX), or by blocking downstream G protein-coupled receptors like the cysteinyl leukotriene receptors (StatPearls, 2023). Corticosteroids further act by inducing annexins that inhibit phospholipase A2, preventing the initial release of arachidonic acid from cellular membranes (Dennis & Norris, 2015).